Annual and Special Shareholders Meeting of ZoomMed Inc.
29 Novembre 2013 - 6:01PM
Marketwired
Annual and Special Shareholders Meeting of ZoomMed Inc.
MONTREAL, QUEBEC--(Marketwired - Nov 29, 2013) - ZoomMed Inc.
(TSX-VENTURE:ZMD), announces it has held its Annual and Special
Meeting of Shareholders as at November 29, 2013.
The purpose of the meeting was:
- To receive the consolidated financial statements of ZoomMed for
the fiscal year ended May 31, 2013 and the independent auditors'
report;
- To elect the board of directors composed of:
- Micheline Luneau
- André Marmet
- Yves Marmet
- Nicolas Matziorinis
- Bruno Floriani
- Marie-Hélène Pinard
- Robert Powell
- To appoint Mazars Harel Drouin as the independent auditor and
authorize the directors to fix their remuneration;
- To approve ZoomMed's stock option plan, a 10% rolling stock
option plan;
About ZoomMed
The Company builds and operates "ZoomMed's communication
network", a clinical information exchange platform between
physicians and the various other stakeholders of the healthcare
sector, such as pharmacists, specialists, pharmaceutical
corporations, laboratories, specialized clinics and others. The
cornerstone of this network is ZoomMed's "ZRx Prescriber", a
technological innovative Web application that enables physicians to
use a wireless device, such as IPhone™, IPad™, Google Android™ or
computers, to write and rapidly deliver scripts. Since it is a
stand-alone product, it can easily be integrated to any Electronic
Medical Record application (EMR).
The Company also offers "PraxisLab", a new pharmacy management
software that enhances all aspects of the prescription filling
process and the complete pharmacy patient file management.
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in policies of the TSX Venture
Exchange) accepts responsibility for the adequacy or accuracy of
this release. Statements made in this news release that are not
historical facts are "forward-looking statements" and readers are
cautioned that any such statements are not guarantees of future
performance, and that actual developments or results, may vary
materially from those in these "forward-looking"
statement.
ZoomMedMr. Yves MarmetPresident and Chief Executive Officer(450)
678-5457, Ext 228info@zoommed.comwww.zoommed.com
Zoommed (TSXV:ZMD)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Zoommed (TSXV:ZMD)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024